☆ 4.6 Article

The use of direct oral anticoagulants for primary thromboprophylaxis in ambulatory cancer patients: Guidance from the SSC of the ISTH

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)

期刊

JOURNAL OF THROMBOSIS AND HAEMOSTASIS

卷 17, 期 10, 页码 1772-1778

出版社

WILEY

DOI: 10.1111/jth.14564

关键词

-

类别

Hematology Peripheral Vascular Disease

资金

NHLBI [HL143365]
Italian Association of Cancer Research (AIRC)
Sondra and Stephen Hardis Chair in Oncology
National Heart, Lung and Blood Institute (Consortium Linking Oncology with Thrombosis) [CLOT-U01HL143402]
University of Ottawa in Cancer and Thrombosis

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Article Hematology

Thromboprophylaxis for venous thromboembolism prevention in hospitalized patients with cirrhosis: Guidance from the SSC of the ISTH

Lara N. Roberts, Virginia Hernandez-Gea, Maria Magnusson, Simon Stanworth, Jecko Thachil, Armando Tripodi, Ton Lisman

Summary: Hospital-associated venous thromboembolism is a significant cause of morbidity and mortality in patients with cirrhosis. The use of thromboprophylaxis in these patients is challenging due to the uncertain balance between thrombosis and bleeding risk. This guidance document provides pragmatic recommendations on VTE prevention for hospitalized patients with cirrhosis, including drug selection and timing.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)

添加到收藏夹

Review Hematology

Direct oral anticoagulants versus aspirin for primary thromboprophylaxis in patients with multiple myeloma undergoing outpatient therapy: A systematic review and updated meta-analysis

Thomaz Alexandre Costa, Nicole Felix, Bruno Almeida Costa, Amanda Godoi, Alleh Nogueira, Adriana Rossi

Summary: Multiple myeloma patients undergoing anti-myeloma therapy have an increased risk of venous thromboembolism (VTE). Current guidelines recommend low-dose direct oral anticoagulants (DOACs) as an alternative to aspirin for thromboprophylaxis. A systematic review and meta-analysis comparing DOACs with aspirin showed that DOACs had a significantly lower incidence of VTE. Bleeding event rates did not differ significantly between the two groups. This suggests that DOACs may be a preferable option for thromboprophylaxis in multiple myeloma patients, but further research is needed to evaluate the optimal strategy.

BRITISH JOURNAL OF HAEMATOLOGY (2023)

添加到收藏夹

Article Hematology

Characteristics and outcomes of patients on concurrent direct oral anticoagulants and targeted anticancer therapies-TacDOAC registry: Communication from the ISTH SSC Subcommittee on Hemostasis and Malignancy

Tzu-Fei Wang, Lisa Baumann Kreuziger, Avi Leader, Galia Spectre, Ming Y. Lim, Andrew Gahagan, Radhika Gangaraju, Kristen M. Sanfilippo, Ranjeeta Mallick, Jeffrey I. Zwicker, Marc Carrier

Summary: This international registry study evaluated outcomes of patients receiving concurrent DOACs and targeted anticancer therapies, showing a higher incidence of bleeding compared to thrombosis, particularly with BTK inhibitors. Larger prospective studies are needed to further investigate these findings.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)

添加到收藏夹

Article Hematology

Recurrent bleeding and thrombotic events after resumption of oral anticoagulants following gastrointestinal bleeding: Communication from the ISTH SSC Subcommittee on Control of Anticoagulation

Matteo Candeloro, Nick van Es, Nathan Cantor, Sam Schulman, Marc Carrier, Walter Ageno, Jesus Aibar, Marco Paolo Donadini, Roisin Bavalia, Marie-Pier Arsenault, Michiel Coppens, Noemi Ferrante, Andrea D'Addezio, Stefano Sormani, Ettore Porreca, Marcello Di Nisio

Summary: Anticoagulant treatment after gastrointestinal bleeding is associated with a lower risk of thromboembolism and death, but higher risk of recurrent bleeding. The risk of recurrent bleeding is influenced more by patient characteristics than by the timing of anticoagulation resumption.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)

添加到收藏夹

Article Hematology

Good practice statements for antithrombotic therapy in the management of COVID-19: Guidance from the SSC of the ISTH

Alex C. Spyropoulos, Jean M. Connors, James D. Douketis, Mark Goldin, Beverley J. Hunt, Taiwo R. Kotila, Renato D. Lopes, Sam Schulman

Summary: Despite the availability of high-quality trial data, there are still questions about the optimal patient selection, use of antithrombotics in different clinical settings, thromboprophylaxis in special patient populations, and management of acute thrombosis in hospitalized COVID-19 patients. The International Society on Thrombosis and Haemostasis (ISTH) formed a panel to develop recommendations on the use of anticoagulants and antiplatelet agents for COVID-19 patients. The panel agreed on 17 Good Practice Statements (GPS) to guide antithrombotic management in various clinical settings.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)

添加到收藏夹

Article Hematology

Periprocedural management of abnormal coagulation parameters and thrombocytopenia in patients with cirrhosis: Guidance from the SSC of the ISTH

Lara N. Roberts, Ton Lisman, Simon Stanworth, Virginia Hernandez-Gea, Maria Magnusson, Armando Tripodi, Jecko Thachil

Summary: Prolonged prothrombin time and thrombocytopenia are common in patients with cirrhosis, but they do not necessarily reflect the overall hemostatic balance or bleeding risk in the periprocedural setting. It is important to carefully evaluate bleeding risk and manage hemostatic abnormalities in these patients during procedures.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)

添加到收藏夹

Review Hematology

The use of direct oral anticoagulants for thromboprophylaxis or treatment of cancer-associated venous thromboembolism: a meta-analysis and review of the guidelines

Norah S. Alsubaie, Shahad M. Al Rammah, Reema A. Alshouimi, Mohammed Y. Alzahrani, Majed S. Al Yami, Abdulaali R. Almutairi, Osamah M. Alfayez, Ghazwa B. Korayem, Omar A. Almohammed

Summary: DOACs show a lower risk of symptomatic VTE and VTE recurrence in cancer patients, but the risk of bleeding remains a significant concern. Clinical decisions should be made by assessing individual patient's risk of VTE and bleeding.

THROMBOSIS JOURNAL (2021)

添加到收藏夹

Article Geriatrics & Gerontology

Frailty phenotype as a predictor of bleeding and mortality in ambulatory patients receiving direct oral anticoagulants

Matteo Candeloro, Marcello Di Nisio, Nicola Potere, Lorenzo Di Pizio, Enzo Secinaro, Claudia De Flaviis, Camilla Federici, Maria Domenica Guglielmi, Silvana Pardi, Sam Schulman, Ettore Porreca

Summary: This study found that frailty phenotype can identify patients at higher risk of bleeding and all-cause mortality in AF or VTE patients receiving DOAC treatment. Frailty assessment could be valuable in guiding targeted interventions to improve patient prognosis.

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2022)

添加到收藏夹

Article Hematology

Peri-procedure management of antithrombotic agents and thrombocytopenia for common procedures in oncology: Guidance from the SSC of the ISTH

Tzu-Fei Wang, Kristen M. Sanfilippo, James Douketis, Anna Falanga, John Karageorgiou, Anthony Maraveyas, Thomas L. Ortel, Gerald Soff, Suresh Vedantham, Jeffrey Zwicker

Summary: This document aims to provide practical guidance in the management of antithrombotic agents and thrombocytopenia around the time of common procedures in patients with cancer.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)

添加到收藏夹

Article Hematology

Results of an international survey on adherence with anticoagulation in children, adolescents, and young adults: Communication from the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and Hemostasis

Meghan E. McGrady, Kevin Todd, Vera Ignjatovic, Sophie Jones, Mattia Rizzi, Lori Luchtman-Jones, Courtney D. Thornburg

Summary: Medical professionals often make inaccurate observations and interpretations, calling for more scientific approaches in their research.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)

添加到收藏夹

Article Hematology

Lupus anticoagulant laboratory diagnosis by applying the 2020 ISTH-SSC guidelines

L. Talon, V. Fourneyron, S. Senectaire, M. Tardieu, M. Tillier, A. Trapani, A. Trayaud, A. Vaissade, A. F. Sapin, A. Lebreton, T. Sinegre

Summary: A study was conducted to investigate and compare the results and interpretations of lupus anticoagulant (LA) testing following the ISTH-SSC guidelines or available alternatives. The use of in-house cut-off values and pooled normal plasma (PNP) for ratio normalization, as well as ratio interpretation using the index of circulating anticoagulant, showed comparable testing outcomes. Understanding the characteristics of the mixing test is crucial for maximizing its diagnostic potential.

THROMBOSIS RESEARCH (2023)

添加到收藏夹

Article Hematology

Use of direct oral anticoagulants in patients with obesity for treatment and prevention of venous thromboembolism: Updated communication from the ISTH SSC Subcommittee on Control of Anticoagulation

Karlyn A. Martin, Jan Beyer-Westendorf, Bruce L. Davidson, Menno V. Huisman, Per Morten Sandset, Stephan Moll

Summary: The review examined the use of DOACs for VTE treatment and prevention in patients with obesity, as well as their application in bariatric surgery. Updated guidance recommendations on the use of DOACs in patients with obesity for VTE treatment and prevention were provided.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)

添加到收藏夹

Article Medicine, General & Internal

Direct oral anticoagulant use and risk of severe COVID-19

B. Flam, V Wintzell, J. F. Ludvigsson, J. Martensson, B. Pasternak

Summary: The study found that ongoing DOAC use was not associated with reducing the risk of severe COVID-19, suggesting that early outpatient DOAC initiation would not modify prognosis.

JOURNAL OF INTERNAL MEDICINE (2021)

添加到收藏夹

Article Medicine, General & Internal

Warfarin is associated with higher rates of epistaxis compared to direct oral anticoagulants: A nationwide propensity score-weighted study

Arnar B. Ingason, Edward Rumba, Johann P. Hreinsson, Arnar S. Agustsson, Sigrun H. Lund, Daniel A. Palsson, Indridi E. Reynisson, Brynja R. Gudmundsdottir, Pall T. Onundarson, Geir Tryggvason, Einar S. Bjornsson

Summary: This study aims to compare the rates of clinically relevant epistaxis between different oral anticoagulants. The results show that warfarin treatment is associated with higher rates of clinically relevant epistaxis compared to direct oral anticoagulants.

JOURNAL OF INTERNAL MEDICINE (2022)

添加到收藏夹

Article Hematology

Novel bleeding risk score for patients with atrial fibrillation on oral anticoagulants, including direct oral anticoagulants

Luise Adam, Martin Feller, Lamprini Syrogiannouli, Cinzia Del-Giovane, Jacques Donze, Christine Baumgartner, Daniel Segna, Carmen Floriani, Laurent Roten, Urs Fischer, Stefanie Aeschbacher, Giorgio Moschovitis, Jurg Schlapfer, Dipen Shah, Peter Amman, Richard Kobza, Matthias Schwenkglenks, Michael Kuehne, Leo H. Bonati, Jurg Beer, Stefan Osswald, David Conen, Drahomir Aujesky, Nicolas Rodondi

Summary: This study successfully developed a bleeding risk prediction model for AF patients on oral anticoagulants, with factors such as age over 75 years, history of cancer, prior major hemorrhage, and arterial hypertension included in the final prediction model. The model showed good calibration and discrimination with a Brier score of 0.23 and a c-statistic of 0.71 at 12 months follow-up.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)

添加到收藏夹

Article Hematology

Incidence and impact of anticoagulation-associated abnormal menstrual bleeding in women after venous thromboembolism

C. M. M. de Jong, M. Blondon, C. Ay, A. Buchmuller, J. Beyer-Westendorf, J. Biechele, L. Bertoletti, G. Colombo, M. P. Donadini, S. V. Hendriks, L. Jara-Palomares, S. Nopp, P. Ruiz-Artacho, P. Stephan, C. Tromeur, T. Vanassche, P. E. Westerweel, F. A. Klok

Summary: Preliminary data and clinical experience suggest an increased risk of abnormal uterine bleeding (AUB) in women of reproductive age treated with anticoagulants, but there is a lack of solid data. In a study involving 98 women diagnosed with acute venous thromboembolism (VTE), 2 out of 3 women experienced AUB during anticoagulation treatment, with a significant negative impact on their quality of life (QoL).

BLOOD (2022)

添加到收藏夹

Article Hematology

Extracellular vesicles from amniotic fluid, milk, saliva, and urine expose complexes of tissue factor and activated factor VII

Yong Hu, Andreas Repa, Ton Lisman, Guelen Yerlikaya-Schatten, Chi Hau, Ingrid Pabinger, Cihan Ay, Rienk Nieuwland, Johannes Thaler

Summary: This study found that extracellular vesicles (EVs) in amniotic fluid, milk, saliva, and urine expose functional extrinsic tenase complexes that can trigger blood clotting. These EVs promote clotting in both normal plasma and FVII-deficient plasma, and their activity is inhibited by antibodies.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)

添加到收藏夹

Article Hematology

The von Willebrand factor-binding aptamer rondaptivon pegol as a treatment for severe and nonsevere hemophilia A

Cihan Ay, Katarina D. Kovacevic, Daniel Kraemmer, Christian Schoergenhofer, Georg Gelbenegger, Christa Firbas, Peter Quehenberger, Petra Jilma-Stohlawetz, James C. Gilbert, Shuhao Zhu, Martin Beliveau, Franz Koenig, Alfonso Iorio, Bernd Jilma, Ulla Derhaschnig, Ingrid Pabinger

Summary: This study evaluated the safety, pharmacokinetics, and pharmacodynamics of rondaptivon pegol in patients with hemophilia A. The results showed that rondaptivon pegol was well tolerated and significantly increased the levels of FVIII and VWF in patients with hemophilia A.

BLOOD (2023)

添加到收藏夹

Article Hematology

Peri-procedure management of antithrombotic agents and thrombocytopenia for common procedures in oncology: Guidance from the SSC of the ISTH

Tzu-Fei Wang, Kristen M. Sanfilippo, James Douketis, Anna Falanga, John Karageorgiou, Anthony Maraveyas, Thomas L. Ortel, Gerald Soff, Suresh Vedantham, Jeffrey Zwicker

Summary: This document aims to provide practical guidance in the management of antithrombotic agents and thrombocytopenia around the time of common procedures in patients with cancer.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)

添加到收藏夹

Article Hematology

The prevalence of thrombocytopenia in patients with acute cancer-associated thrombosis

Charles Hsu, Rushad Patell, Jeffrey I. Zwicker

Summary: Venous thromboembolism (VTE) and thrombocytopenia are common complications in patients with cancer. This study evaluated the prevalence of thrombocytopenia among patients with acute cancer-associated thrombosis (CAT) and found that concurrent diagnoses of CAT and thrombocytopenia are very common, especially in patients with hematologic malignancies.

BLOOD ADVANCES (2023)

添加到收藏夹

Article Transplantation

Growth differentiation factor-15 predicts major bleeding, major adverse cardiac events and mortality in patients with end-stage kidney disease on haemodialysis: findings from the VIVALDI study

Stephan Nopp, Oliver Koenigsbruegge, Sabine Schmaldienst, Renate Klauser-Braun, Matthias Lorenz, Ingrid Pabinger, Marcus Saeemann, Cihan Ay

Summary: This study found that in patients with end-stage kidney disease (ESKD), growth differentiation factor-15 (GDF-15) can predict the risk of major bleeding, cardiovascular events, and death, and may be a valuable marker for guiding treatment decisions.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2023)

添加到收藏夹

Article Health Care Sciences & Services

Peri-Interventional Triple Therapy with Dabigatran Modifies Vasomotion after Bare-Metal Stent Implantation in a Pig Coronary Artery Model

Rayyan Hemetsberger, Serdar Farhan, Dominika Lukovic, Katrin Zlabinger, Judit Hajagos-Toth, Judit Bota, Hector M. Garcia-Garcia, Cihan Ay, Eslam Samaha, Robert Gaspar, Rita Garamvoelgyi, Kurt Huber, Andreas Spannbauer, Mariann Gyoengyoesi

Summary: Peri-interventional triple therapy with dabigatran in a pig model of coronary artery stenting has been found to ameliorate local inflammation and disturb vasomotion, without reducing neointimal formation.

JOURNAL OF PERSONALIZED MEDICINE (2023)

添加到收藏夹

Article Hematology

Risk of venous thromboembolism or hemorrhage among individuals with chronic kidney disease on prophylactic anticoagulant after hip or knee arthroplasty

Tzu-Fei Wang, Nicholas Grubic, Marc Carrier, Mark Canney, Aurelien Delluc, Gregory L. Hundemer, Gregory Knoll, Alejandro Lazo-Langner, David Massicotte-Azarniouch, Peter Tanuseputro, Manish M. Sood

Summary: Chronic kidney disease patients undergoing hip or knee arthroplasty face a high risk of thrombosis and bleeding. A retrospective cohort study in Ontario, Canada showed that, compared to LMWH, DOAC was associated with a lower risk of venous thrombosis and a higher risk of hemorrhage in these patients.

AMERICAN JOURNAL OF HEMATOLOGY (2023)

添加到收藏夹

Article Biochemistry & Molecular Biology

Circulatory miR-411-5p as a Novel Prognostic Biomarker for Major Adverse Cardiovascular Events in Patients with Atrial Fibrillation

Stephan Nopp, M. Leontien van der Bent, Daniel Kraemmer, Oliver Koenigsbruegge, Johann Wojta, Ingrid Pabinger, Cihan Ay, Anne Yael Nossent

Summary: In this study, the researchers investigated the potential of circulating microRNAs as prognostic biomarkers for major adverse cardiovascular events in patients with atrial fibrillation. The results suggest that miR-411-5p could be a valuable biomarker for predicting MACE in AF patients.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

添加到收藏夹

Article Medicine, General & Internal

Early discharge and home treatment of patients with acute pulmonary embolism in the tertiary care setting

Stephan Nopp, Julia Bohnert, Thomas Mayr, Daniel Steiner, Helmut Prosch, Irene Lang, Wilhelm Behringer, Karin Janata-Schwatczek, Cihan Ay

Summary: This study describes the characteristics, discharge, and outcome of outpatients diagnosed with acute pulmonary embolism (PE) at a tertiary care center. Results showed that 156 out of 709 patients (22%) were discharged and received home treatment, with a 2.4-fold increase in home treatment rates during the study period. The 30-day mortality rate was 4.9%.

INTERNAL AND EMERGENCY MEDICINE (2023)

添加到收藏夹

Article Oncology

Plasma Clot Properties in Patients with Pancreatic Cancer

Johannes Thaler, Gerald Prager, Ingrid Pabinger, Cihan Ay

Summary: Using a modified plasma clot formation assay, we found an increased plasma clot formation rate and fibrin fiber thickness in pancreatic cancer patients compared to healthy controls. When a tissue factor blocking antibody was added, the clot formation rate decreased significantly in patients, fibrin fiber thickness decreased in patients and controls, the lag phase remained unchanged, and the time to peak fibrin generation increased in patients. These findings suggest the presence of a prothrombotic state in pancreatic cancer patients, dependent on tissue factor.

CANCERS (2023)

添加到收藏夹

Article Medicine, Research & Experimental

The unfolded protein response links ER stress to cancer-associated thrombosis

Oluwatoyosi Muse, Rushad Patell, Christian G. Peters, Moua Yang, Emale El-Darzi, Sol Schulman, Anna Falanga, Marina Marchetti, Laura Russo, Jeffrey I. Zwicker, Robert Flaumenhaft

Summary: Thrombosis is a common complication of advanced cancer, and our study reveals that activation of the unfolded protein response (UPR) in cancer cells can lead to increased release of prothrombotic particles, providing a mechanistic link between ER stress and cancer-associated thrombosis.

JCI INSIGHT (2023)

添加到收藏夹

Review Oncology

Immune Checkpoint Inhibitors-Associated Thrombosis: Incidence, Risk Factors and Management

Tzu-Fei Wang, Marc Carrier

Summary: Immune checkpoint inhibitors have become an integral part of cancer treatment, but they carry the risk of thrombosis, which can lead to various complications. Recent studies have shown that C-reactive protein dynamics may serve as a biomarker for thrombosis. Furthermore, early findings suggest that factor Xa inhibitors used for cancer-associated thrombosis may have potential synergistic antitumor effects when combined with ICIs.

CURRENT ONCOLOGY (2023)

添加到收藏夹

Review Hematology

Gene therapy for haemophilia A and B, from basic principles to clinical implementation: An illustrated review

Cihan Ay, Laurent Frenzel, Karen Pinachyan, Sandra Le Quellec

Summary: This article aims to provide a comprehensive summary of the whole process of AAV-based gene therapy, from basic principles to clinical implementation, through an illustrated review.

HAEMOPHILIA (2023)

添加到收藏夹

Article Hematology

Growth differentiation factor-15 and prediction of cancer-associated thrombosis and mortality: a prospective cohort study

Stephan Nopp, Florian Moik, Simon Kraler, Cornelia Englisch, Matthias Preusser, Arnold von Eckardstein, Ingrid Pabinger, Thomas F. Luescher, Cihan Ay

Summary: GDF-15 is strongly associated with survival in cancer patients, independent of established risk factors. Although an association was identified with ATE and VTE in univariable analysis, GDF-15 was not independently associated with these outcomes and failed to improve established VTE prediction models.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2023)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.